bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.02.748779

Wolf microevolution in the melting pot: range expansion, population sympatry, dynamic mosaic admixture zone and asymmetric gene flow

Abstract

Here we describe substantial range shifts of historically differentiated wolf populations and formation of novel sympatric zones during the recent decade in Central Europe. This region provides a natural laboratory for testing alternative scenarios of population interactions from continued isolation or restricted gene flow to progressive population fusion, while prompting a reassessment of their geographic ranges. Based on sampling across the Czech Republic and Slovakia obtained from large-scale monitoring programmes over five wolf years (2020/21_2024/25), complemented by comparative material from neighbouring regions, we analysed mitochondrial haplotypes, autosomal microsatellite genotypes and sex-linked loci. The Central European population with Baltic ancestry predominated across large parts of Central Europe including the Bohemian Massif with enclaves in the Western Carpathians. The Carpathian population was predominant in Slovakia, with a smaller satellite occurrence in the northern part of the Bohemian Massif. Alpine population was centred in the Alps but extended into southern parts of Bohemian Massif and Central German Uplands. Following the sporadic occurrence of admixed individuals, broad mosaic and dynamic sympatric zones have formed in the Czech Republic and Slovakia in the last decade. These scenarios could be facilitated by the presence of intermediate habitats and isolation of the Bohemian Massif structural basin, framed by a massive ring fault system. Recent-immigration estimates are asymmetric, with the largest mean contributions from the Alpine to the Central European population and from the Central European to the Carpathian population, with the second case potentially linked to source-sink dynamics driven by the hunting pressure within the Carpathian population (whereas the others are protected year-round). Whether increasing admixture will enhance viability of populations (that currently have small effective sizes) through genetic rescue or carry risks of outbreeding depression remains uncertain, highlighting the need for continued transboundary monitoring within conservation biology framework.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Srutova, J., Tkacova, N., Cetkovska, E., Eliasova, K., Veselovska, L., Ungrova, L., Montoya, K., Skrobanek, M., Mateju, P., Dula, M., Vorel, A., Mokry, J., Mikslova, K., Collet, S., Nowak, C., Rolle, F., Marucco, F., Szewczyk, M., Myslajek, R., Nowak, S., Findo, S., Antal, V., Kutal, M., Jelinkova, J., Bolfikova, B. C., Hulva, P.. 2026-09-04. Wolf microevolution in the melting pot: range expansion, population sympatry, dynamic mosaic admixture zone and asymmetric gene flow. https://doi.org/10.64898/2026.09.02.748779

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗